MedTrace Logo

Evaluation of the Beneficial Health Effects of an Additive-free Meat Product in Healthy Subjects (HIPOCARNE)

NCT06392893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2024-05-01

No results posted yet for this study

Summary

The purpose of this research is to test the hypothesis that the consumption of meat products without additives, in comparison with their analogues with additives, could be beneficial in terms of modifying health markers. A 5-week clinical trial with two parallel arms will be performed with two parallel arms. Changes in different serum biomarkers of lipid metabolism, glucose, oxidative stress and inflammation will be analysed. Biomarkers related to digestive health, such as short chain fatty acid (SCFA) production and impact on the gut microbiota, will also be evaluated. Finally, factors such as body mass index (BMI), body fat percentage and markers of exposure to additives will be measured.

Conditions

Interventions

COMBINATION_PRODUCT

Meat product without additives and allergens

Baseline time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine. Consumption of meat products without additives and allergens (6 days a week; 5 weeks). Final time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.

COMBINATION_PRODUCT

Commercial meat product

Baseline time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine. Consumption of commercial meat products (6 days a week; 5 weeks). Final time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.

Sponsors & Collaborators

  • Universidad de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2023-06-07
Completion
2023-06-07

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392893 on ClinicalTrials.gov